Gender Differences in the Effects of Angiotensin Receptor Blockers on Cardiovascular Disease

By  

Current Pharmaceutical Design, Vol. 17, Iss. 11, 2011-04 ,pp. : 1090-1094

Bentham Science Publishers

Access to resources Recommend Favorite

Antiproliferative Efficacy of Angiotensin II Receptor Blockers in Prostate Cancer

By  

Current Cancer Drug Targets, Vol. 5, Iss. 5, 2005-08 ,pp. : 307-323

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the renin–angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers

By Kjeldsen Sverre E   Lyle Paulette A   Tershakovec Andrew M   Devereux Richard B   Oparil Suzanne   Dahlöf Björn   de Faire Ulf   Fyhrquist Frej   Ibsen Hans   Kristianson Krister   Lederballe-Pedersen Ole   Lindholm Lars H   Nieminen Markku S   Omvik Per   Wedel Hans  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. : 729-745

Informa Healthcare

Access to resources Recommend Favorite

Drug interactions with angiotensin receptor blockers

By Böhler Steffen   Pittrow David   Bramlage Peter   Kirch Wilhelm  

Expert Opinion on Drug Safety, Vol. 4, Iss. 1, 2005-01 ,pp. : 7-18

Informa Healthcare

Access to resources Recommend Favorite

Vascular benefits of angiotensin receptor blockers

By Voors   Adriaan A  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 7, 2007-06 ,pp. : 987-997

Informa Healthcare

Access to resources Recommend Favorite